ECOLAB INC.
ECLAPI behind this page
ECL Q4 2025 request
Playground key active
/api/financials?ticker=ECL&year=2025&quarter=4
Pick an endpoint and run the request.
Income Statement
| Metric | Q4 2025 | Q4 2024 | YoY |
|---|---|---|---|
| Revenue | 4,196 | 4,005.2 | +4.8% |
Show Product Lines breakouts |
|||
| Product and equipment sales | 3,297.2 | 3,158 | +4.4% |
| Product and equipment sales · Global Institutional and Specialty | 1,257 | 1,207.5 | +4.1% |
| Product and equipment sales · Global Life Sciences | 197.3 | 177.3 | +11.3% |
| Product and equipment sales · Global Water | 1,842.9 | 1,773.2 | +3.9% |
| Service and lease sales | 898.8 | 847.2 | +6.1% |
| Service and lease sales · Global Institutional and Specialty | 291.1 | 281.2 | +3.5% |
| Service and lease sales · Global Life Sciences | 10 | 10.9 | -8.3% |
| Service and lease sales · Global Pest Elimination | 316.5 | 293.8 | +7.7% |
| Service and lease sales · Global Water | 281.2 | 261.3 | +7.6% |
Show Business Segments breakouts |
|||
| Global Institutional and Specialty | 1,548.1 | 1,488.7 | +4.0% |
| Global Institutional and Specialty · Asia Pacific | 91.2 | 83.5 | +9.2% |
| Global Institutional and Specialty · CA | 62.8 | 61.6 | +1.9% |
| Global Institutional and Specialty · CN | 50.2 | 46.5 | +8.0% |
| Global Institutional and Specialty · Europe | 269.9 | 259.1 | +4.2% |
| Global Institutional and Specialty · India, Middle East and Africa | 28.6 | 29.7 | -3.7% |
| Global Institutional and Specialty · Latin America | 55.2 | 50.6 | +9.1% |
| Global Institutional and Specialty · Operating Segments | 1,499 | 1,458.7 | +2.8% |
| Global Institutional and Specialty · US | 990.2 | 957.7 | +3.4% |
| Global Life Sciences | 207.3 | 188.2 | +10.1% |
| Global Life Sciences · Asia Pacific | 20.1 | 11.1 | +81.1% |
| Global Life Sciences · CA | 0.9 | 0.7 | +28.6% |
| Global Life Sciences · CN | 15 | 16.3 | -8.0% |
| Global Life Sciences · Europe | 110 | 97.2 | +13.2% |
| Global Life Sciences · India, Middle East and Africa | 8 | 10.6 | -24.5% |
| Global Life Sciences · Latin America | 4.6 | 6.3 | -27.0% |
| Global Life Sciences · Operating Segments | 191.4 | 179.7 | +6.5% |
| Global Life Sciences · US | 48.7 | 46 | +5.9% |
| Global Pest Elimination | 316.5 | 293.8 | +7.7% |
| Global Pest Elimination · Asia Pacific | 9.5 | 8.5 | +11.8% |
| Global Pest Elimination · CA | 3.4 | 3.1 | +9.7% |
| Global Pest Elimination · CN | 15.8 | 15.1 | +4.6% |
| Global Pest Elimination · Europe | 55.8 | 50.9 | +9.6% |
| Global Pest Elimination · India, Middle East and Africa | 1.8 | 1.9 | -5.3% |
| Global Pest Elimination · Latin America | 16.1 | 14.4 | +11.8% |
| Global Pest Elimination · Operating Segments | 307.2 | 287.9 | +6.7% |
| Global Pest Elimination · US | 214.1 | 199.9 | +7.1% |
| Global Water | 2,124.1 | 2,034.5 | +4.4% |
| Global Water · Asia Pacific | 256.8 | 252 | +1.9% |
| Global Water · CA | 61.4 | 57.5 | +6.8% |
| Global Water · CN | 102.8 | 99 | +3.8% |
| Global Water · Europe | 458.6 | 418.6 | +9.6% |
| Global Water · India, Middle East and Africa | 150.3 | 143 | +5.1% |
| Global Water · Latin America | 231.9 | 207.6 | +11.7% |
| Global Water · Operating Segments | 2,017.4 | 1,967.6 | +2.5% |
| Global Water · US | 862.3 | 856.8 | +0.6% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | 181 | 111.3 | +62.6% |
| Operating Segments | 4,015 | 3,893.9 | +3.1% |
| Cost of Revenue | 2,348.4 | 2,269.1 | +3.5% |
Show Product Lines breakouts |
|||
| Product and equipment sales | 1,832.9 | 1,769 | +3.6% |
| Service and lease sales | 515.5 | 500.1 | +3.1% |
Show Business Segments breakouts |
|||
| Corporate · Operating Segments | 0.1 | 2 | -95.0% |
| Global Institutional and Specialty · Operating Segments | 764.9 | 758.5 | +0.8% |
| Global Life Sciences · Operating Segments | 105.8 | 107 | -1.1% |
| Global Pest Elimination · Operating Segments | 169.5 | 164 | +3.4% |
| Global Water · Operating Segments | 1,205.2 | 1,173.3 | +2.7% |
Show — breakouts |
|||
| Cost of Revenue | -0.6 | 0.3 | -300.0% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 2,245.5 | 2,204.8 | +1.8% |
| Selling, General & Administrative | 1,061 | 1,050 | +1.0% |
Show Business Segments breakouts |
|||
| Corporate · Operating Segments | 49.3 | 48.4 | +1.9% |
| Global Institutional and Specialty · Operating Segments | 399.3 | 412.5 | -3.2% |
| Global Life Sciences · Operating Segments | 53 | 41.1 | +29.0% |
| Global Pest Elimination · Operating Segments | 75.3 | 81.2 | -7.3% |
| Global Water · Operating Segments | 450.6 | 444.1 | +1.5% |
Show — breakouts |
|||
| Selling, General & Administrative | -0.6 | 2.1 | -128.6% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 1,027.5 | 1,027.3 | 0.0% |
| Other Nonrecurring Income Expense | 74.6 | 103.3 | -27.8% |
Show Product Lines breakouts |
|||
| Product and equipment, and service and lease · Cost Of Sales | 0.1 | 2.1 | -95.2% |
Show Business Segments breakouts |
|||
| Corporate · Operating Segments | 72.6 | 103.4 | -29.8% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 72.6 | 103.4 | -29.8% |
Show Income Statement Location breakouts |
|||
| Cost Of Sales | 0.1 | 2.1 | -95.2% |
| Special (gains) and charges | 74.6 | 103.3 | -27.8% |
| Operating Income | 712 | 582.8 | +22.2% |
Show Business Segments breakouts |
|||
| Corporate · Operating Segments | -122 | -153.8 | +20.7% |
| Global Institutional and Specialty · Operating Segments | 334.8 | 287.7 | +16.4% |
| Global Life Sciences · Operating Segments | 32.6 | 31.6 | +3.2% |
| Global Pest Elimination · Operating Segments | 62.4 | 42.7 | +46.1% |
| Global Water · Operating Segments | 361.6 | 350.2 | +3.3% |
Show Consolidation Items breakouts |
|||
| Material Reconciling Items | 42.6 | 24.4 | +74.6% |
| Operating Segments | 669.4 | 558.4 | +19.9% |
| Non-Operating Income (Expense) | -12.6 | -13.2 | +4.5% |
| Interest Expense Net | 64.3 | 61.7 | +4.2% |
Show — breakouts |
|||
| Interest Expense Net | -0.2 | -0.5 | +60.0% |
| Income Before Taxes | 660.3 | 534.3 | +23.6% |
| Income Tax Expense (Benefit) | 91.7 | 54.8 | +67.3% |
| Net Income | 568.6 | 479.5 | +18.6% |
Show Equity Components breakouts |
|||
| Noncontrolling Interest | 4.7 | 6.6 | -28.8% |
| Parent | 563.9 | 472.9 | +19.2% |
| Retained Earnings | 563.9 | 472.9 | +19.2% |
| Net Income Loss Attributable To Noncontrolling Interest | 4.7 | 6.6 | -28.8% |
| Net Income | 563.9 | 472.9 | +19.2% |
| EPS (Basic) | 2 | 1.67 | +19.8% |
| EPS (Diluted) | 1.98 | 1.65 | +20.0% |
| Wtd Avg Shares (Basic) | -0.2 | -0.3 | +33.3% |
| Wtd Avg Shares (Diluted) | -0.1 | -0.2 | +50.0% |
| Interest Income | -18.6 | -17.5 | -6.3% |
| Comprehensive Income | 593.5 | 344.7 | +72.2% |
| Professional Fees (Q) | — | — | — |
Show Disposal Group Classification breakouts |
|||
| Disposal Group Disposed Of By Sale Not Discontinued Operations · Global surgical solutions business | 0.6 | 1 | -40.0% |
Show Income Statement Location breakouts |
|||
| Special (gains) and charges · One Ecolab Initiative Program | 6.3 | 7.5 | -16.0% |
| Interest Expense | 82.9 | 79.2 | +4.7% |
| Operating Lease Lease Income | 146 | 136.6 | +6.9% |
Balance Sheet
| Metric | Q4 2025 | Q4 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 646.2 | 1,256.8 | -48.6% |
| Accounts Receivable | 3,249.4 | 2,865 | +13.4% |
| Inventory | 1,490.4 | 1,464.9 | +1.7% |
| Other Assets Current | 569.6 | 439 | +29.7% |
| Total Current Assets | 5,955.6 | 6,025.7 | -1.2% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 4,276.6 | 3,752.4 | +14.0% |
| Goodwill | 9,227 | 7,907.3 | +16.7% |
Show Business Segments breakouts |
|||
| Global Institutional and Specialty | 1,041.5 | 1,024.3 | +1.7% |
| Global Life Sciences | 2,490.4 | 2,408.7 | +3.4% |
| Global Pest Elimination | 189.6 | 169.4 | +11.9% |
| Global Water | 5,505.5 | 4,304.9 | +27.9% |
Show Business Acquisition breakouts |
|||
| Series Of Individually Immaterial Business Acquisitions | 17.4 | 156.7 | -88.9% |
| Operating Lease Right-of-Use Assets | 765.9 | 723.2 | +5.9% |
| Other Non-Current Assets | 782.7 | 670.4 | +16.8% |
| Total Assets | 24,696.3 | 22,387.8 | +10.3% |
| Intangible Assets | 2,458.5 | 2,078.8 | +18.3% |
| Deferred Tax Assets | 181 | 155.5 | +16.4% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 3,688.5 | 3,308.8 | +11.5% |
| Current Liabilities | |||
| Debt Current | 870.4 | 615.7 | +41.4% |
| Accounts Payable | 2,071 | 1,810 | +14.4% |
| Employee Related Liabilities Current | 721.5 | 727.4 | -0.8% |
| Accrued Income Taxes Current | 134.3 | 127 | +5.7% |
| Other Liabilities Current | 1,737.5 | 1,512.7 | +14.9% |
| Total Current Liabilities | 5,534.7 | 4,792.8 | +15.5% |
| Commercial Paper (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| U.S. commercial paper program | 100 | — | — |
| Non-Current Liabilities | |||
| Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent | 546.1 | 634.9 | -14.0% |
Show Retirement Plan Type breakouts |
|||
| Defined Benefit Postretirement Health Coverage · US | 90.7 | 91.5 | -0.9% |
| Pension Plans Defined Benefit · Foreign Plan | 383.7 | 370.5 | +3.6% |
| Pension Plans Defined Benefit · US | 66.9 | 142.8 | -53.2% |
| Deferred Tax Liabilities | 329.9 | 280 | +17.8% |
| Other Non-Current Liabilities | 518.7 | 366.2 | +41.6% |
| Total Liabilities | 14,891.8 | 13,598.6 | +9.5% |
| Other Liabilities | |||
| Long Term Debt And Capital Lease Obligations | 7,365.9 | 6,949.2 | +6.0% |
| Operating Lease Liability Noncurrent Excluded From Long Term Debt | 596.5 | 575.5 | +3.6% |
| Stockholders' Equity | |||
| Common Stock | 369.4 | 367.8 | +0.4% |
| Additional Paid In Capital Common Stock | 7,521.3 | 7,159.6 | +5.1% |
| Retained Earnings | 12,834 | 11,517.1 | +11.4% |
| Accumulated Other Comprehensive Income | -1,874.3 | -1,982 | +5.4% |
| Treasury Stock Value | -9,079.6 | -8,305.2 | -9.3% |
| Total Stockholders' Equity | 9,770.8 | 8,757.3 | +11.6% |
| Minority Interest | 33.7 | 31.9 | +5.6% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 9,804.5 | 8,789.2 | +11.6% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -1,874.3 | -1,982 | +5.4% |
| Additional Paid In Capital | 7,521.3 | 7,159.6 | +5.1% |
| Common Stock | 369.4 | 367.8 | +0.4% |
| Noncontrolling Interest | 33.7 | 31.9 | +5.6% |
| Parent | 9,770.8 | 8,757.3 | +11.6% |
| Retained Earnings | 12,834 | 11,517.1 | +11.4% |
| Treasury Stock Common | -9,079.6 | -8,305.2 | -9.3% |
| Total Liabilities & Equity | 24,696.3 | 22,387.8 | +10.3% |
Cash Flow Statement
| Metric | YTD Q4 2025 | YTD Q4 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation | 178.8 | 161.2 | +10.9% |
| Adjustment For Amortization | 77.3 | 74.3 | +4.0% |
| Deferred Income Taxes And Tax Credits | 23.7 | -40.8 | +158.1% |
| Stock-Based Compensation | 27.1 | 25.3 | +7.1% |
| Pension And Other Postretirement Benefit Contributions | -10.7 | -10.7 | -0.0% |
| Pension And Other Postretirement Benefit Expense | 4.6 | 2.8 | +64.3% |
| Restructuring Costs | 31.3 | 35.4 | -11.6% |
| Gain Loss On Sale Of Business | 0 | 1 | -100.0% |
| Other Non-Cash Items | 8.4 | 6.6 | +27.3% |
| Change in Accounts Receivable | -35.6 | -37.4 | +4.8% |
| Change in Inventory | 74 | 48 | +54.2% |
| Increase Decrease In Other Operating Assets | 49.5 | 16.8 | +194.6% |
| Change in Accounts Payable | 115.5 | 22.3 | +417.9% |
| Increase Decrease In Other Operating Liabilities | -22.4 | -17.6 | -27.3% |
| Net Cash from Operations | 1,090.1 | 766.7 | +42.2% |
| Investing Activities | |||
| Capital Expenditures | -332.1 | -359.7 | +7.7% |
| Proceeds From Sale Of Productive Assets | 5.9 | 8 | -26.3% |
| Payments To Acquire Businesses And Interest In Affiliates | -1,620.8 | -256.5 | -531.9% |
| Proceeds From Divestiture Of Businesses Net Of Cash Divested | 0 | 0 | — |
| Other Investing Activities | -31.2 | -19.3 | -61.7% |
| Net Cash from Investing | -1,978.2 | -627.5 | -215.3% |
| Financing Activities | |||
| Proceeds From Repayments Of Short Term Debt | 97.1 | -1.4 | +7035.7% |
| Repayments Of Long Term Debt | 0 | 0 | — |
| Share Repurchases | -409.2 | -2.8 | -14514.3% |
| Payments Of Dividends Common Stock | -189.2 | -161.4 | -17.2% |
| Proceeds From Stock Options Exercised | 46.2 | 26.6 | +73.7% |
| Proceeds From Payments For Other Financing Activities | -3.1 | -1.1 | -181.8% |
| Net Cash from Financing | -431.6 | -140.1 | -208.1% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 10.1 | -3.4 | +397.1% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations | -1,309.6 | -4.3 | -30355.8% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 646.2 | 1,256.8 | -48.6% |
Values in millions USD. Source: SEC EDGAR 10-K filing.